跳至主要内容
临床试验/NL-OMON47415
NL-OMON47415已完成不适用

ong-term effects of renal mitochondrial vitality in severe infections and sepsis - LONGEVITIES

niversitair Medisch Centrum Groningen0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Adult patients, aged between 18 and 85 years
  • - Clinical suspicion of a pulmonary or urinary tract infection

排除标准

  • - Congenital mitochondrial diseases
  • - Renal transplant recipients
  • - Patients on renal replacement therapy
  • - Hepatic failure (Child Pugh C)
  • - Hepatorenal syndrome

研究者

相似试验

尚未招募
不适用
ongterm effects of severe infections and sepsis.infection, sepsis, mitochondrial dysfunction
NL-OMON21743niversity Medical Center Groningen100
进行中(未招募)
1 期
Evaluating the short-term renal and systemic effects of Dapagliflozin in non-diabetic patients with stage IV CKD at risk of ESKD because of severe renal insufficiency and persistent proteinuria: A prospective, randomized, double-blind, placebo-controlled, cross-over study
EUCTR2021-000726-10-ITIRCCS- ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI32
招募中
不适用
Examination of the effects on renal function and prognosis of various diuretics for liver cirrhosisiver cirrhosis
JPRN-UMIN000040179Hokkaido University400
进行中(未招募)
1 期
Evaluation of the impact of renal function on the pharmacokinetics of hydroxyurea (Siklos®) in patients with sickle cell disease with normal renal function, with hyperfiltration, or with renal failure. DARH studySiklos is indicated for the prevention of recurrent painful vaso-occlusive crises including acute chest syndrome in adults, adolescents and children older than 2 years suffering from symptomatic sickle cell syndrome.MedDRA version: 17.1Level: LLTClassification code 10040643Term: Sickle cell crisisSystem Organ Class: 100000004851
EUCTR2014-005033-31-FRAddmedica S.A.S
招募中
不适用
Consideration the changes of renal function for renal cell carcinoma patients, administered the molecular target drugs: axitinib, sunitinib and sorafenibRenal cell carcinoma
JPRN-UMIN000019393Dokkyo Medical University, Department of Urology30